ATyr Pharma Stock Forecast - Naive Prediction
| ATYR Stock | 0.75 0 0.53% |
The Naive Prediction forecasted value of aTyr Pharma on the next trading day is expected to be 0.76 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.67. ATyr Stock Forecast is based on your current time horizon. Although ATyr Pharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of ATyr Pharma's systematic risk associated with finding meaningful patterns of ATyr Pharma fundamentals over time.
As of today the rsi of ATyr Pharma's share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.15) | EPS Estimate Current Year (0.82) | EPS Estimate Next Year (0.56) | Wall Street Target Price 4.3571 | EPS Estimate Current Quarter (0.19) |
Using ATyr Pharma hype-based prediction, you can estimate the value of aTyr Pharma from the perspective of ATyr Pharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards ATyr Pharma using ATyr Pharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards ATyr using crowd psychology based on the activity and movement of ATyr Pharma's stock price.
ATyr Pharma Short Interest
An investor who is long ATyr Pharma may also wish to track short interest. As short interest increases, investors should be becoming more worried about ATyr Pharma and may potentially protect profits, hedge ATyr Pharma with its derivative instruments, or be ready for some potential downside.
200 Day MA 2.9462 | Short Percent 0.3053 | Short Ratio 11.77 | Shares Short Prior Month 30.4 M | 50 Day MA 0.7428 |
aTyr Pharma Hype to Price Pattern
Investor biases related to ATyr Pharma's public news can be used to forecast risks associated with an investment in ATyr. The trend in average sentiment can be used to explain how an investor holding ATyr can time the market purely based on public headlines and social activities around aTyr Pharma. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ATyr Pharma Implied Volatility | 2.0 |
ATyr Pharma's implied volatility exposes the market's sentiment of aTyr Pharma stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ATyr Pharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ATyr Pharma stock will not fluctuate a lot when ATyr Pharma's options are near their expiration.
The Naive Prediction forecasted value of aTyr Pharma on the next trading day is expected to be 0.76 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.67.
ATyr Pharma after-hype prediction price | USD 0.75 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of ATyr Pharma to cross-verify your projections. Open Interest Against 2026-03-20 ATyr Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast ATyr Pharma's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in ATyr Pharma's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for ATyr Pharma stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current ATyr Pharma's open interest, investors have to compare it to ATyr Pharma's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of ATyr Pharma is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in ATyr. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
ATyr Pharma Additional Predictive Modules
Most predictive techniques to examine ATyr price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ATyr using various technical indicators. When you analyze ATyr charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
ATyr Pharma Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the ATyr Pharma's financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 2013-12-31 | Previous Quarter 17.2 M | Current Value 6.2 M | Quarterly Volatility 16.6 M |
ATyr Pharma Naive Prediction Price Forecast For the 24th of January
Given 90 days horizon, the Naive Prediction forecasted value of aTyr Pharma on the next trading day is expected to be 0.76 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.67.Please note that although there have been many attempts to predict ATyr Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that ATyr Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
ATyr Pharma Stock Forecast Pattern
| Backtest ATyr Pharma | ATyr Pharma Price Prediction | Buy or Sell Advice |
ATyr Pharma Forecasted Value
In the context of forecasting ATyr Pharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. ATyr Pharma's downside and upside margins for the forecasting period are 0.01 and 5.21, respectively. We have considered ATyr Pharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of ATyr Pharma stock data series using in forecasting. Note that when a statistical model is used to represent ATyr Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.3502 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0274 |
| MAPE | Mean absolute percentage error | 0.0364 |
| SAE | Sum of the absolute errors | 1.672 |
Predictive Modules for ATyr Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as aTyr Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ATyr Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ATyr Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of ATyr Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ATyr Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ATyr Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ATyr Pharma Estimiated After-Hype Price Volatility
In the context of predicting ATyr Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ATyr Pharma's historical news coverage. ATyr Pharma's after-hype downside and upside margins for the prediction period are 0.04 and 5.20, respectively. We have considered ATyr Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ATyr Pharma is abnormally volatile at this time. Analysis and calculation of next after-hype price of aTyr Pharma is based on 3 months time horizon.
ATyr Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as ATyr Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ATyr Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ATyr Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.33 | 4.45 | 0.00 | 0.01 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.75 | 0.75 | 0.00 |
|
ATyr Pharma Hype Timeline
aTyr Pharma is presently traded for 0.75. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. ATyr is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at -0.33%. %. The volatility of related hype on ATyr Pharma is about 12714.29%, with the expected price after the next announcement by competition of 0.74. About 63.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.87. Some equities with similar Price to Book (P/B) outperform the market in the long run. aTyr Pharma recorded a loss per share of 0.83. The entity had not issued any dividends in recent years. The firm had 1:14 split on the 1st of July 2019. Given the investment horizon of 90 days the next anticipated press release will be in about 9 days. Check out Historical Fundamental Analysis of ATyr Pharma to cross-verify your projections.ATyr Pharma Related Hype Analysis
Having access to credible news sources related to ATyr Pharma's direct competition is more important than ever and may enhance your ability to predict ATyr Pharma's future price movements. Getting to know how ATyr Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ATyr Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ALXO | Alx Oncology Holdings | (0.07) | 7 per month | 5.68 | 0.01 | 12.82 | (9.41) | 27.69 | |
| CAMP | CAMP4 THERAPEUTICS PORATION | 0.43 | 9 per month | 6.26 | 0.12 | 12.31 | (12.90) | 47.02 | |
| QNCX | Quince Therapeutics | (0.01) | 10 per month | 4.08 | 0.14 | 11.88 | (7.90) | 42.36 | |
| MGX | Metagenomi Common Stock | 0.02 | 9 per month | 0.00 | (0.22) | 6.02 | (8.57) | 25.29 | |
| RPTX | Repare Therapeutics | 0.06 | 11 per month | 1.47 | 0.11 | 3.95 | (3.26) | 35.71 | |
| UNCY | Unicycive Therapeutics | (0.32) | 9 per month | 4.04 | 0.14 | 7.31 | (6.59) | 17.45 | |
| RLMD | Relmada Therapeutics | (0.32) | 10 per month | 3.93 | 0.18 | 12.44 | (8.60) | 36.80 | |
| ACRV | Acrivon Therapeutics Common | (0.11) | 5 per month | 7.75 | 0.05 | 8.21 | (9.09) | 66.02 | |
| HYFT | ImmunoPrecise Antibodies | 0.10 | 8 per month | 5.26 | 0.11 | 11.88 | (7.34) | 28.44 | |
| DTIL | Precision BioSciences | (0.13) | 9 per month | 0.00 | (0.17) | 5.64 | (8.82) | 28.04 |
Other Forecasting Options for ATyr Pharma
For every potential investor in ATyr, whether a beginner or expert, ATyr Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ATyr Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ATyr. Basic forecasting techniques help filter out the noise by identifying ATyr Pharma's price trends.ATyr Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ATyr Pharma stock to make a market-neutral strategy. Peer analysis of ATyr Pharma could also be used in its relative valuation, which is a method of valuing ATyr Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
ATyr Pharma Market Strength Events
Market strength indicators help investors to evaluate how ATyr Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ATyr Pharma shares will generate the highest return on investment. By undertsting and applying ATyr Pharma stock market strength indicators, traders can identify aTyr Pharma entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 0.75 | |||
| Day Typical Price | 0.75 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0) |
ATyr Pharma Risk Indicators
The analysis of ATyr Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ATyr Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting atyr stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.08 | |||
| Standard Deviation | 4.34 | |||
| Variance | 18.8 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for ATyr Pharma
The number of cover stories for ATyr Pharma depends on current market conditions and ATyr Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ATyr Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ATyr Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
ATyr Pharma Short Properties
ATyr Pharma's future price predictability will typically decrease when ATyr Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of aTyr Pharma often depends not only on the future outlook of the potential ATyr Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ATyr Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 74.3 M | |
| Cash And Short Term Investments | 72.1 M |
Additional Tools for ATyr Stock Analysis
When running ATyr Pharma's price analysis, check to measure ATyr Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma is operating at the current time. Most of ATyr Pharma's value examination focuses on studying past and present price action to predict the probability of ATyr Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma's price. Additionally, you may evaluate how the addition of ATyr Pharma to your portfolios can decrease your overall portfolio volatility.